Pharmacoepidemiological studies: methodology and regulation
Abstract
Keywords
About the Authors
D. Yu. BelousovRussian Federation
A. E. Cheberda
Russian Federation
References
1. Guidance for Industry and FDA Staff: Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM243537.pdf.
2. Guideline on good Pharmacovigilance practices (GVP), Module VIII -Post-authorization safety studies (PASS). http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129137.pdf.
3. Guidance for the format and content of the protocol of non-interventional post-authorization safety studies. http://www.ema.europa.eu/docs/en_GB/document_library/0ther/2012/10/WC500133174.pdf.
4. AHRQ 2012. Methods guide for effectiveness and comparative effectiveness reviews. http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-andreports/?pageaction=displayproduct&productid=31.
5. Guidelines for good pharmacoepidemiology practice (GPP). pharmacoepidemiology and drug safety. 2016; 25: 2-10.
6. Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М.: Медиа Сфера, 1998; 352.
7. Зырянов С.К. Фармакоэпидемиология вчера, сегодня и завтра. Фарматека. 2003; 3: 13-17.
8. Прикладная фармакоэпидемиология. Учебник под редакцией академика РАМН В.И. Петрова. М.: 2008; 384.
9. Галанкин Т.Л., Колбин А.С. Роль рандомизированных исследований в фармакоэпидемиологии. Фармакоэкономика. 2014; 7 (1): 5-9.
10. Галанкин Т.Л., Вербицкая Е.В. Фармакоэпидемиология. Методическое пособие. / Под общей редакцией Колбина А.С. Первый Санкт-Петербургский Государственный Медицинский Университет им. акад. И.П. Павлова, 2015 г.
11. Рачина С.А., Козлов Р.С., Белькова Ю.А. Фармакоэпидемиология: от теоретических основ к практическому применению. Фармакоэкономика, 2015; 7: 1: 33-38.
12. Strom B.L. Study Designs Available for Pharmacoepidemiology Studies. In: Strom B.L., editor. Pharmacoepidemiology. 3d ed. New York: John Wiley & Sons, Inc. - 2000; 17-30.
13. Strom B.L. (ed). Pharmacoepidemiology (Fourth Edition). Sussex: John Wiley, 2005.
14. Strom B.L., Kimmel S.E. (eds). Textbook of Pharmacoepidemiology. Sussex: John Wiley, 2006.
15. Suruki R.Y., Chan K.A. Basic Pharmacoepidemiology Methods. In: Hartzema A.G., Tilson H.H, Chan K.A, editors. Pharmacoepidemiology and therapeutic risk assessment. Harwey Whitney Books, Cincinatti. 2008; P. 219-38.
16. Pharmacoepidemiology and drug safety http://www3.interscience.wiley.com/journal/5669/home
17. International Society for Pharmacoepidemiology http://www.pharmacoepi.org/index.cfm
18. International Society of Pharmacovigilance http://www.isoponline.org/.
19. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance http://www.encepp.eu
20. ICH http://www.ich.org/products/guidelines.html
21. STROBE statement http://www.strobe-statement.org/
22. CONSORT statement including variants http://www.consort-statement.org/
23. MOOSE statement http://jama.jamanetwork.com/article.aspx?articleid=192614
24. GRACE principles http://www.graceprinciples.org/grace-p.html
25. The PCORI Methodology Report http://www.pcori.org/assets/2013/11/PC0RI-Methodology-Report.pdf
Review
For citations:
Belousov D.Yu., Cheberda A.E. Pharmacoepidemiological studies: methodology and regulation. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2017;(1):34-41. (In Russ.)